December 16, 2025 · Form 4 insider transaction
MIGNONE ROBERTO sold 77,400 shares of Teva Pharmaceutical Industries Limited at $30.24 per share, a transaction worth $2.34M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.225 to $30.25, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.; The 367,600 Ordinary Shares disclosed in Table I of this Form 4 are held of record by Swiftcurrent Master Fund Ltd. (the "Fund"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may be deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaims beneficial ownership of the Ordinary Shares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose.